Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs – Decrypt
In brief Novo Nordisk rolled out an oral version of Wegovy in the U.S., marking the first pill-based GLP-1 approved specifically for weight loss. GLP-1 drugs from Novo Nordisk and Eli Lilly have surged in popularity, though injections, side effects, and cost have remained barriers for some patients. The pill builds on years of work...
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
